The global cell-based assays market is expected to reach $19.92 Billion by 2022 from $ 13.34 Billion in 2017, at a CAGR of 8.4%.
A number of factors, such as growing funding and investments in R&D, the increasing prevalence of chronic disorders, increase in drug discovery activities, and the advantages of cell-based assays over alternative technologies are expected to drive the growth of this market.
Ask for Sample copy of Cell-based assay research paper @
Major industry players launched innovative products to improve and maintain their market shares. Players also expanded across geographies via partnerships and acquisitions. Becton, Dickinson and Company (U.S.), Cisbio Bioassays (France), PerkinElmer, Inc. (U.S.), and Danaher Corporation (U.S.) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. Further, these leaders have products for all end users in this segment, a strong geographical presence, and more importantly, focus on continuous product innovations.
Target Audience for this Report:
- Cell-based assays manufacturers and vendors
- Research associations related to drug discovery
- Healthcare providers (hospitals, laboratories, medical schools, and outpatient clinics)
- Various research and consulting firms
- Distributors of cell-based assays
- Academic and Research Institutes
Access full research report at
The primary interviews conducted for this report can be categorized as follows:
- By Company Type – Tier 1 – 25 %, Tier 2 – 35% and Tier 3 – 40%
- By Designation – C level – 35%, Director level – 25%, Others – 40%
- By Region – North America – 43%, Europe – 19%, APAC – 29%, RoW – 9%
The global market is segmented by product, application, end user, and region. By product, the global market is segmented into consumables, instruments, service and software. The consumables segment is expected to lead the global cell-based assays market in 2017. The rising prevalence of chronic disorders and technical innovations in the field are key growth factors of this subsegment.
Table of Contents
1.1 Objectives of the Study
1.2 Market Definition
2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study
3 Executive Summary
4 Cell-Based Assays Market: Premium Insights
4.1 Cell-Based Assays: Market Overview
4.2 Geographic Analysis: Global Market, By End User (2017)
4.3 Geographical Snapshot
4.4 Global Market, By Application, 2017 vs 2022
Download Sample @
By application, the market is classified into drug discovery, basic research, ADME studies, predictive toxicology and other applications. The drug manufacturers are mostly confined to using cell-based assays during the drug development process, this drives the drug discovery applications segment and helps the segment hold the largest share of the cell-based assays market in 2017.
On the basis of end users, the equipment market is segmented into pharmaceutical and biotechnology companies, academic and government institutions, contract research organizations, and other end users. In 2017, the pharmaceutical and biotechnology companies segment accounted for the greatest share and is also projected to grow at the highest rate during the forecast period. Technological improvements and the growing usage of cell-based assays, especially in developed countries of North America and Europe are major factors fueling the growth in this end-user segment.
Browse related report
- Single-cell Analysis Market @ http://www.rnrmarketresearch.com/single-cell-analysis-market-by-product-beads-microplate-reagents-flow-cytometer-microscope-spectrophotometer-cell-type-human-animal-technique-ngs-pcr-application-cancer-neurology-nipd-ivf-ctcs-ts-to-2021-market-report.html
The report analyses the cell-based assays market by products, applications, end users, and regions. Apart from a comprehensive geographic &product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise of product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market. The market research data, current market size, and forecast of the future trends in the market will help established players as well as new entrants make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the cell-based assays market.